stockrowArrowhead Pharmaceuticals, Inc. (ARWR) vs Madrigal Pharmaceuticals, Inc. (MDGL)
- Arrowhead Pharmaceuticals, Inc. ARWR 58.23 +1.34%
- Madrigal Pharmaceuticals, Inc. MDGL 388.53 −2.89%
Arrowhead Pharmaceuticals, Inc. and Madrigal Pharmaceuticals, Inc. are both Biotechnology companies. Madrigal Pharmaceuticals, Inc. is the larger, with a market value of $9.3B against $8.1B — 1.1× the size. Madrigal Pharmaceuticals, Inc. grew revenue faster over the last twelve months: 92.8% against 16.1%. Madrigal Pharmaceuticals, Inc. has the higher net margin (−10.9% vs −47.8%) and the lower return on invested capital (−1,480.3% vs 0.00%). Across the 17 metrics below, Madrigal Pharmaceuticals, Inc. leads on 9 and Arrowhead Pharmaceuticals, Inc. on 8.
Valuation
Profitability
| Metric | ARWR | MDGL | Biotechnology median |
|---|---|---|---|
| Gross margin | 100.00% | 90.96% | 65.16% |
| Operating margin | (33.82%) | (10.69%) | 0.00% |
| Net margin | (47.79%) | (10.89%) | 0.00% |
| Free cash flow margin | (11.22%) | (11.81%) | 0.00% |
| Return on equity | (64.91%) | (24.82%) | (50.12%) |
| Return on assets | (18.32%) | (11.12%) | (45.60%) |
| Return on invested capital | 0.00% | (1,480.32%) | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack